yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38050504-19CBF028-3D54-42B0-8E0B-90A80CE07CB5
Q38050504-19CBF028-3D54-42B0-8E0B-90A80CE07CB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38050504-19CBF028-3D54-42B0-8E0B-90A80CE07CB5
siRNA and cancer immunotherapy.
P2860
Q38050504-19CBF028-3D54-42B0-8E0B-90A80CE07CB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38050504-19CBF028-3D54-42B0-8E0B-90A80CE07CB5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
08b556cc29f0ef77056f510bd813c71646695c2d
P2860
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer